Most importantly, the expression of METTL3 and CDCP1 is correlated with the progression status of the bladder cancers, further supporting the role of METTL3-mediated m6A pathway in bladder cancer oncogenesis. The gene discussed is CDCP1; the disease is urinary bladder cancer.